Anthony Bergmann
Director of Finance/CFO at CAPRICOR THERAPEUTICS, INC.
Net worth: 16 167 $ as of 30/03/2024
Profile
Anthony J.
Bergmann has held the following positions in his career: Treasurer & Finance Director at Capricor, Inc. starting in 2013, and Chief Financial Officer at Capricor Therapeutics, Inc. starting in 2018.
He completed his undergraduate degree at Providence College in 2008 and obtained an MBA from USC Marshall School of Business in 2013.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/03/2024 | 2,381 ( 0.01% ) | 16 167 $ | 30/03/2024 |
Anthony Bergmann active positions
| Companies | Position | Start |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Director of Finance/CFO | 31/12/2017 |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Director of Finance/CFO | 31/12/2011 |
Training of Anthony Bergmann
| Providence College | Undergraduate Degree |
| USC Marshall School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Stock Market
- Insiders
- Anthony Bergmann
